Leina Moro Pérez holds a bachelor of science in biochemistry and molecular biology from Havana University. Leina works as Purification Specialist in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana, focusing on the comparability study of therapeutic monoclonal antibodies by circular dichroism and fluorescence, the establishment of the purification process of the anti-PD1 monoclonal antibody and the characterization of monoclonal antibodies by DO, SDS-PAGE, western blot, isoelectric focusing and FG-HPLC, circular dichroism, and fluorescence methods.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1
and chronic conditions such as cancer
1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061